T1	p 272 286	98 patients to
T2	i 6 37	Cophenylcaine spray vs. placebo
T3	i 50 64	nasendoscopy :
T4	i 165 184	topical preparation
T5	i 295 362	cophenylcaine or placebo nasal spray before flexible nasendoscopy .
T6	i 967 1002	cophenylcaine for nasal preparation
T7	o 203 228	fibreoptic nasendoscopy .
T8	o 365 386	visual analogue scale
T9	o 389 394	1-100
T10	o 416 469	pain , unpleasantness of taste and overall discomfort
T11	o 482 491	. Overall
T12	o 528 555	minimal pain and discomfort
T13	o 612 638	pain or overall discomfort
T14	o 690 699	sensation
T15	o 703 712	bad taste
T16	o 816 841	overall unpleasantness of
T17	o 872 876	pain
T18	o 889 919	and secondarily unpleasantness
T19	o 923 930	taste .
T20	o 967 980	cophenylcaine